Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR Vaccine for COVID-19 Prevention in Healthcare Professionals
NCT04357028Phase 3Suspended
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of M-M-R II in coronavirus disease 2019 (COVID-19), sponsored by Kasr Al Ainy Hospital. Started Jul 2020; status: suspended.
02
Drugs
M-M-R II
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04357028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357028.